Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide, and its incidence continues to increase. Despite improvements in both medical and surgical therapies, HCC remains associated with poor outcomes due to its high rates of recurrence and mortality. Approximate...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassese, Gianluca, Han, Ho-Seong, Lee, Boram, Lee, Hae Won, Cho, Jai Young, Panaro, Fabrizio, Troisi, Roberto Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627435/
https://www.ncbi.nlm.nih.gov/pubmed/36340753
http://dx.doi.org/10.4254/wjh.v14.i10.1862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627435/
https://www.ncbi.nlm.nih.gov/pubmed/36340753
http://dx.doi.org/10.4254/wjh.v14.i10.1862

Ejemplares similares